WHO ICTRP trial
Novel biomarker for pulmonary fibrotic sarcoidosis
JPRN-jRCT1090220381 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCT1090220381 |
|---|---|
| Public title | Novel biomarker for pulmonary fibrotic sarcoidosis |
| Scientific title | Novel biomarker for pulmonary fibrotic sarcoidosis - Biomarker for pulmonary sarcoidosis |
| Primary sponsor | Susumu sakamoto |
| Secondary sponsors | Tetsuo Yamaguchi |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | Japan |
| Conditions | sarcoidosis |
| Interventions | Intervention type:PROCEDURE Name of intervention:Sample collection by healthy volunteers Dose form / Japanese Medical Device Nomenclature: Route of administration / Site of application:NOT APPLICABLE Dose per administration: Dosing… |
| Registration date | Jul 9, 2018 |
| Target size | 60 |
| Secondary IDs | JMA-IIA00381 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: